IL17A and psoriasis: For instance, IL-36 and IL-17C mainly act synergistically to enhance tissue inflammation (90–92); overexpression of IL-20 can lead to epidermal changes characteristic of psoriasis (93–95); and IL-19 potentiates the effects of IL-17A via a positive feedback mechanism (96, 97).